Additional information
| Active substance | Gliclazide |
|---|---|
| Storage conditions | Store at room temperature away from moisture and heat |
| Side effects | Hypoglycemia, gastrointestinal disturbances (e.g., nausea, indigestion), dizziness, headache |
| Effects | Lowers blood glucose levels by stimulating insulin release from pancreatic beta cells |
| Dosage (sports) | Not applicable |
| Dosage (medical) | Typically 40-120 mg per day, depending on patient response and formulation (immediate or extended release) |
| Half-life | 10-12 hours |
| Main action | Hypoglycemic agent |
| Substance class | Sulfonylurea |
| Formula | C15H21N3O3S |
| Chemical name | 1-(3-azabicyclo[3.3.0]oct-3-yl)-3-(p-tolylsulfonyl)urea |
| Trade name | Diamicron, among others |
| Blood pressure | No significant impact on blood pressure |
| WAREHOUSE | International Warehouse 2 |
| Also known as | Glyclazide |
| Lab Test | Blood glucose monitoring, hemoglobin A1c |
| Aromatization | No |
| Hepatotoxicity | No |
| HBR | No |
| Water Retention | No |
| Acne | No |
| Use in sports | Not typically used in sports |
| Manufacturer | Servier |
Reviews
There are no reviews yet.